title: Albendazole-responsive disseminated Tubulinosema acridophagus in a patient with chronic lymphocytic leukaemia.
authors.affiliation: Division of Infectious Diseases, Department of Medicine, University of Calgary, Canada. Electronic address: William.connors@albertahealthservices.ca.
authors.forename: W J
authors.initials: WJ
authors.lastname: Connors
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Calgary, Canada; Calgary Laboratory Services, Calgary, Alberta, Canada.
authors.forename: J A
authors.initials: JA
authors.lastname: Carson
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Calgary, Canada; Calgary Laboratory Services, Calgary, Alberta, Canada.
authors.forename: W W
authors.initials: WW
authors.lastname: Chan
authors.affiliation: Division of Infectious Diseases, Department of Medicine, University of Calgary, Canada; Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Canada.
authors.forename: M D
authors.initials: MD
authors.lastname: Parkins
mesh_terms: D015766:Albendazole / Q000008:administration & dosage*; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D005260:Female; D006651:Histocytochemistry; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D008853:Microscopy; D046529:Microscopy, Electron, Transmission; D016814:Microsporidia / Q000145:classification / Q000302:isolation & purification*; D016881:Microsporidiosis / Q000175:diagnosis* / Q000473:pathology*; D008875:Middle Aged; D012867:Skin / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D015766:Albendazole